vs
KORU Medical Systems, Inc.（KRMD）与RETRACTABLE TECHNOLOGIES INC（RVP）财务数据对比。点击上方公司名可切换其他公司
KORU Medical Systems, Inc.的季度营收约是RETRACTABLE TECHNOLOGIES INC的1.2倍（$10.9M vs $9.4M），KORU Medical Systems, Inc.同比增速更快（23.3% vs 4.0%），过去两年KORU Medical Systems, Inc.的营收复合增速更高（15.3% vs 11.5%）
KORU医疗系统公司是一家专业医疗技术企业，主营设计、生产和销售创新型流动输液系统及配套一次性耗材，服务全球家庭护理、临床试验、急症护理领域的医疗机构与患者，专注于提升专科药物输送的安全性与舒适度。
Retractable Technologies Inc是一家专业医疗设备制造商，主打可回缩注射器、安全针头、静脉导管等一次性安全医疗产品，客户覆盖医疗机构、制药企业及公共卫生部门，产品可有效降低医护人员与患者的针刺伤害风险。
KRMD vs RVP — 直观对比
营收规模更大
KRMD
是对方的1.2倍
$9.4M
营收增速更快
KRMD
高出19.2%
4.0%
两年增速更快
KRMD
近两年复合增速
11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.9M | $9.4M |
| 净利润 | — | $-2.3M |
| 毛利率 | 62.6% | -16.2% |
| 营业利润率 | -5.0% | -81.7% |
| 净利率 | — | -24.9% |
| 营收同比 | 23.3% | 4.0% |
| 净利润同比 | — | -162.3% |
| 每股收益（稀释后） | $-0.11 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRMDRVP
| Q4 25 | $10.9M | $9.4M | ||
| Q3 25 | $10.4M | $10.1M | ||
| Q2 25 | $10.2M | $10.4M | ||
| Q1 25 | $9.6M | $8.3M | ||
| Q4 24 | $8.8M | $9.1M | ||
| Q3 24 | $8.2M | $10.3M | ||
| Q2 24 | $8.4M | $6.0M | ||
| Q1 24 | $8.2M | $7.6M |
净利润KRMDRVP
| Q4 25 | — | $-2.3M | ||
| Q3 25 | $-778.0K | $371.0K | ||
| Q2 25 | $-206.9K | $-87.5K | ||
| Q1 25 | $-1.2M | $-10.5M | ||
| Q4 24 | — | $3.8M | ||
| Q3 24 | $-1.6M | $-1.9M | ||
| Q2 24 | $-988.7K | $-14.2M | ||
| Q1 24 | $-1.9M | $429.4K |
毛利率KRMDRVP
| Q4 25 | 62.6% | -16.2% | ||
| Q3 25 | 60.2% | 16.7% | ||
| Q2 25 | 63.5% | -1.0% | ||
| Q1 25 | 62.8% | -0.0% | ||
| Q4 24 | 62.9% | -27.5% | ||
| Q3 24 | 63.4% | -0.1% | ||
| Q2 24 | 65.0% | -7.0% | ||
| Q1 24 | 62.3% | 25.0% |
营业利润率KRMDRVP
| Q4 25 | -5.0% | -81.7% | ||
| Q3 25 | -8.3% | -36.2% | ||
| Q2 25 | -3.1% | -49.1% | ||
| Q1 25 | -12.9% | -56.4% | ||
| Q4 24 | -18.0% | -79.6% | ||
| Q3 24 | -20.8% | -49.6% | ||
| Q2 24 | -14.1% | -95.6% | ||
| Q1 24 | -23.9% | -39.3% |
净利率KRMDRVP
| Q4 25 | — | -24.9% | ||
| Q3 25 | -7.5% | 3.7% | ||
| Q2 25 | -2.0% | -0.8% | ||
| Q1 25 | -12.1% | -126.6% | ||
| Q4 24 | — | 41.6% | ||
| Q3 24 | -19.3% | -18.6% | ||
| Q2 24 | -11.7% | -234.9% | ||
| Q1 24 | -23.6% | 5.7% |
每股收益（稀释后）KRMDRVP
| Q4 25 | $-0.11 | $-0.09 | ||
| Q3 25 | $0.02 | $0.01 | ||
| Q2 25 | $0.00 | $0.00 | ||
| Q1 25 | $0.03 | $-0.35 | ||
| Q4 24 | $-0.22 | $0.14 | ||
| Q3 24 | $0.03 | $-0.07 | ||
| Q2 24 | $0.02 | $-0.48 | ||
| Q1 24 | $0.04 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.9M | $2.6M |
| 总债务越低越好 | — | $895.6K |
| 股东权益账面价值 | $17.0M | $74.4M |
| 总资产 | $28.2M | $142.6M |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资KRMDRVP
| Q4 25 | $8.9M | $2.6M | ||
| Q3 25 | $8.5M | $3.4M | ||
| Q2 25 | $8.1M | $3.0M | ||
| Q1 25 | $8.7M | $3.4M | ||
| Q4 24 | $9.6M | $4.2M | ||
| Q3 24 | $8.8M | $3.9M | ||
| Q2 24 | $10.5M | $6.9M | ||
| Q1 24 | $10.8M | $10.0M |
总债务KRMDRVP
| Q4 25 | — | $895.6K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益KRMDRVP
| Q4 25 | $17.0M | $74.4M | ||
| Q3 25 | $16.5M | $76.8M | ||
| Q2 25 | $16.5M | $76.5M | ||
| Q1 25 | $16.3M | $76.6M | ||
| Q4 24 | $16.8M | $87.2M | ||
| Q3 24 | $17.7M | $83.5M | ||
| Q2 24 | $18.7M | $85.4M | ||
| Q1 24 | $19.1M | $99.7M |
总资产KRMDRVP
| Q4 25 | $28.2M | $142.6M | ||
| Q3 25 | $27.1M | $146.4M | ||
| Q2 25 | $25.5M | $147.1M | ||
| Q1 25 | $27.2M | $149.3M | ||
| Q4 24 | $27.2M | $160.7M | ||
| Q3 24 | $27.4M | $157.8M | ||
| Q2 24 | $27.3M | $160.7M | ||
| Q1 24 | $27.5M | $176.0M |
负债/权益比KRMDRVP
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.1M | $-596.5K |
| 自由现金流经营现金流 - 资本支出 | $687.0K | — |
| 自由现金流率自由现金流/营收 | 6.3% | — |
| 资本支出强度资本支出/营收 | 3.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-470.1K | — |
8季度趋势，按日历期对齐
经营现金流KRMDRVP
| Q4 25 | $1.1M | $-596.5K | ||
| Q3 25 | $65.5K | $-1.3M | ||
| Q2 25 | $-460.3K | $-3.7M | ||
| Q1 25 | $-237.5K | $-1.5M | ||
| Q4 24 | $939.6K | $-1.1M | ||
| Q3 24 | $-923.9K | $-5.7M | ||
| Q2 24 | $11.3K | $-2.7M | ||
| Q1 24 | $-346.7K | $-2.0M |
自由现金流KRMDRVP
| Q4 25 | $687.0K | — | ||
| Q3 25 | $13.0K | $-1.3M | ||
| Q2 25 | $-489.2K | $-4.1M | ||
| Q1 25 | $-680.9K | $-1.6M | ||
| Q4 24 | $896.0K | $-1.4M | ||
| Q3 24 | $-2.0M | $-6.5M | ||
| Q2 24 | $-112.9K | $-2.8M | ||
| Q1 24 | $-479.8K | $-2.2M |
自由现金流率KRMDRVP
| Q4 25 | 6.3% | — | ||
| Q3 25 | 0.1% | -13.4% | ||
| Q2 25 | -4.8% | -38.9% | ||
| Q1 25 | -7.1% | -18.8% | ||
| Q4 24 | 10.1% | -15.5% | ||
| Q3 24 | -24.5% | -63.0% | ||
| Q2 24 | -1.3% | -46.8% | ||
| Q1 24 | -5.9% | -29.6% |
资本支出强度KRMDRVP
| Q4 25 | 3.7% | — | ||
| Q3 25 | 0.5% | 0.9% | ||
| Q2 25 | 0.3% | 3.2% | ||
| Q1 25 | 4.6% | 1.0% | ||
| Q4 24 | 0.5% | 3.3% | ||
| Q3 24 | 13.2% | 7.7% | ||
| Q2 24 | 1.5% | 2.0% | ||
| Q1 24 | 1.6% | 3.0% |
现金转化率KRMDRVP
| Q4 25 | — | — | ||
| Q3 25 | — | -3.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.29× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -4.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KRMD
| US | $8.3M | 76% |
| Non Us | $2.6M | 24% |
RVP
暂无分部数据
